A
HLVX

Abingworth’s HilleVax HLVX Stock Holding History

Abingworth’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$30.8M Hold
1,838,486
– – 10.02% 4
2022
Q3 		$31.4M Hold
1,838,486
– – 10.74% 3
2022
Q2 		$19.9M Buy
+1,838,486
New +$21.8M 6.38% 5

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Abingworth's HLVX Position: Q4 2022 in Review

Abingworth held its HilleVax (HLVX) position steady in Q4 2022 at 1,838,486 shares worth $30.8M. The position accounts for 10.02% of the portfolio, ranked #4.

Abingworth first reported a position in HLVX in Q2 2022 and has held it in 3 quarters since. The position peaked at $31.4M in Q3 2022. 55 funds tracked by Wall St. Rank hold HLVX as of Q4 2022.

  • Abingworth held 1,838,486 shares of HilleVax worth $30.8M as of Q4 2022.
  • Abingworth left its HilleVax share count unchanged in Q4 2022.
  • HilleVax made up 10.02% of Abingworth's portfolio in Q4 2022, its #4 holding.
  • Abingworth first reported a position in HilleVax in Q2 2022 and has held it in 3 quarters since.
  • Abingworth's HilleVax position peaked at $31.4M in Q3 2022.
  • 55 funds tracked by Wall St. Rank held HilleVax as of Q4 2022.

Based on Abingworth's 13F filing for Q4 2022, filed 10 Feb 2023.